Post-approval studies (Phase 4)Study completedNCT00981526
What this trial is testing
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Massachusetts, Worcester 66